Literature DB >> 17988986

Microvascular thrombosis in the hepatic vein of a patient with paroxysmal nocturnal hemoglobinuria.

Hideyoshi Noji1, Tsutomu Shichishima, Masatoshi Okamoto, Akiko Shichishima-Nakamura, Hayato Matsumoto, Hiroko Tajima, Kazuei Ogawa, Yukio Maruyama.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by complement-mediated hemolysis, venous thrombosis, and bone marrow failure. In May 2003, a 33-year-old man was admitted to a hospital with right hypochondralgia and fever. He had a history of aplastic anemia. The patient's diagnosis of diffuse microvessel thrombosis in the hepatic vein due to an unknown cause was derived from the findings of a contrast-enhanced computed tomography examination of the abdominal region, angiographic evaluation of abdominal vessels, and pathohistologic examination of a liver biopsy sample. The patient was subsequently treated with warfarin. The abdominal pain and fever continued, however, and anemia gradually appeared. In April 2004, the patient was referred to our hospital to examine the cause of the thrombosis. On admission, slight anemia and a low serum haptoglobin level were observed. A flow cytometry evaluation of CD55 and/or CD59, CD59, and CD48 expression in erythrocytes, granulocytes, and monocytes, respectively, showed that the respective proportions of negative populations were 5.6%, 97.1%, and 96.2%. The patient then received a diagnosis of aplastic anemia/PNH syndrome, which had caused the hemolytic anemia and thrombosis, although no hemoglobinuria had been observed during his clinical course. This patient is, to our knowledge, the first reported case of a PNH patient with thrombosis present only in hepatic microvessels and not in hepatic large vessels, in spite of the presence of few hemolytic events.

Entities:  

Mesh:

Year:  2007        PMID: 17988986     DOI: 10.1532/IJH97.07064

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  23 in total

1.  Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin.

Authors:  H Ninomiya; Y Kawashima; T Nagasawa
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

Review 2.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

3.  Shared and individual specificities of immunodominant cytotoxic T-cell clones in paroxysmal nocturnal hemoglobinuria as determined by molecular analysis.

Authors:  Magdalena Plasilova; Antonio M Risitano; Christine L O'Keefe; Alexander Rodriguez; Marcin Wlodarski; Neal S Young; Jaroslaw Maciejewski
Journal:  Exp Hematol       Date:  2004-03       Impact factor: 3.084

Review 4.  Thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) with particular reference to progressive, diffuse hepatic venous thrombosis.

Authors:  R Peytremann; R S Rhodes; R C Hartmann
Journal:  Ser Haematol       Date:  1972

5.  The kidneys in paroxysmal nocturnal hemoglobinuria.

Authors:  D A Clark; S A Butler; V Braren; R C Hartmann; D E Jenkins
Journal:  Blood       Date:  1981-01       Impact factor: 22.113

Review 6.  New insights into paroxysmal nocturnal hemoglobinuria.

Authors:  W F Rosse
Journal:  Curr Opin Hematol       Date:  2001-03       Impact factor: 3.284

Review 7.  Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.

Authors:  Tsutomu Shichishima; Hideyoshi Noji
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

8.  Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.

Authors:  T Wiedmer; S E Hall; T L Ortel; W H Kane; W F Rosse; P J Sims
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

9.  Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.

Authors:  Jun-Ichi Nishimura; Yuzuru Kanakura; Russell E Ware; Tsutomu Shichishima; Hideki Nakakuma; Haruhiko Ninomiya; Carlos M Decastro; Sharon Hall; Akihisa Kanamaru; Keith M Sullivan; Hideaki Mizoguchi; Mitsuhiro Omine; Taroh Kinoshita; Wendell F Rosse
Journal:  Medicine (Baltimore)       Date:  2004-05       Impact factor: 1.889

10.  High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.

Authors:  M Okamoto; T Shichishima; H Noji; K Ikeda; A Nakamura; K Akutsu; Y Maruyama
Journal:  Leukemia       Date:  2006-04       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.